{"id":446383,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-04-29] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:48:19.271000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-04-29.html?wbdisable=false","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-04-29] April 29, 2025 Our file number: 25-102881-952 The purpose of this Notice of Amendment is to notify about the addition of efanesoctocog alfa, fecal microbiota (human), inavolisib, loncastuximab tesirine,…","rawSnapshotUrl":"/api/snapshots/raw/446383","browseUrl":"https://replay.healtharchive.ca/job-6/20260103114819/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-04-29.html?wbdisable=false#ha_snapshot=446383","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}